Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Direct Line CEO and CFO to step down ahead of Aviva deal

(Sharecast News) - Direct Line's chief executive and chief financial officer are to exit the business at the start of next month as part of the insurer's merger with Aviva. The reshuffle follows last week's news that all regulatory and antitrust approvals regarding the £3.7bn acquisition have been satisfied or waived, with the transaction expected to take effect on 1 July.

CEO Adam Winslow and CFO Jane Poole will serve the first two months of their notice period on garden leave, but be available to transitional support, Aviva said.

Meanwhile, all other non-executive directors of Direct Line will also resign following the deal.

Jason Storah and Stephen Pond, currently the CEO and CFO of Aviva's UK and Ireland general insurance business, respectively, are to step in as Winslow and Poole's successors. Aviva non-executive director Ian Clark has been named as Direct Line's new chair.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.